ArticleACS nano2026

Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma.

Yen-Nhi Ngoc Ta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.